Electrozink Public Joint-Stock Company

As of September 30, 2023, Electrozink Public Joint-Stock Company has 1.40M shares outstanding.

As of September 30, 2023, Electrozink Public Joint-Stock Company trades at an EV/EBITDA multiple of 279.51 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.63 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 279.51 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses.

As of September 30, 2023, Electrozink Public Joint-Stock Company maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2023. Return on assets (ROA) is negative at -17.58, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -32.05, pointing to unprofitable operations over the period. Inventory turnover of 1.19 indicates how many times Electrozink Public Joint-Stock Company sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended September 30, 2023. That works out to an effective tax rate of 20.11, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended September 30, 2023, Electrozink Public Joint-Stock Company posted a gross margin of 7.92, reflecting its pricing power and cost economics. The operating margin of 0.58 and net profit margin of -30.86 provide insight into operational efficiency.

As of September 30, 2023, Electrozink Public Joint-Stock Company has an Altman Z-Score of 0.25, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.